Inside Track: Molecular Testing Guideline for Lung Cancer Updated
Key medical societies are offering new standards for the molecular testing of lung cancers to guide targeted therapies.
Read MorePosted by Elaine Sanchez Wilson | Mar 1, 2018 | Lung Cancer |
Key medical societies are offering new standards for the molecular testing of lung cancers to guide targeted therapies.
Read MorePosted by Elaine Sanchez Wilson | Jan 3, 2018 | Lung Cancer |
The toolkit from the American Society for Clinical Pathology is designed around actionable topics of tumor acquisition and adequacy, specimen handling and ancillary testing, and interpretation and guidelines.
Read MorePosted by Elaine Sanchez Wilson | Dec 6, 2017 | Research |
Gilupi has shared results of a study examining the detection of circulating tumor cells in the blood of pulmonary disease patients.
Read MorePosted by Cassandra Perez | Oct 30, 2017 | Research, Sexually Transmitted Diseases |
A comprehensive literature review finds that the Biodesix VeriStrat test can aid in more precise treatment prognosis to inform treatment choice for patients with non-small cell lung cancer.
Read MorePosted by Cassandra Perez | Oct 22, 2017 | Cancer, Lung Cancer, Molecular Diagnostics, Research |
Patients with early-stage non-small cell lung cancer receive significantly different treatments based on the results of VeriStrat testing.
Read More